John J Alam's Net Worth
$77.6 Million
Who is John J Alam?
John J Alam has an estimated net worth of $77.6 Million. This is based on reported shares across multiple companies, which include CervoMed Inc., VERTEX PHARMACEUTICALS INC / MA, and Pathfinder Cell Therapy, Inc..
SEC CIK
John J Alam's CIK is 0001197014
Past Insider Trading and Trends
2006 was John J Alam's most active year for acquiring shares with 21 total transactions. John J Alam's most active month to acquire stocks was the month of December. 2007 was John J Alam's most active year for disposing of shares, totalling 39 transactions. John J Alam's most active month to dispose stocks was the month of November. 2006 saw John J Alam paying a total of $586,132.00 for 154,950 shares, this is the most they've acquired in one year. In 2007 John J Alam cashed out on 126,579 shares for a total of $2,380,416.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CervoMed Inc. (CRVO) Snapshot price: $14.45
CEO & PresidentJohn J Alam owns 729,539 units of Common Stock which is worth $10,541,838.55. In the year 2024 John J Alam filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -1.68% | -12.50K |
—
|
—
| 729.54K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP, Med. Dev. Group & CMOJohn J Alam owns 136,792 units of Common Stock which is worth $64,018,656.00.acquired a total of 256,919 shares in VERTEX PHARMACEUTICALS INC / MA at a cost of $1,711,083.82, John also disposed a total of 144,887 shares of VERTEX PHARMACEUTICALS INC / MA equalling to $4,771,142.83.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$23.14 | -$80,892.06 | 136.79K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$18.21 | -$106,088.56 | 136.79K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
$18.02 | -$103,610.04 | 136.79K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$18.61 | -$111,279.96 | 136.79K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
$18.88 | -$114,925.32 | 136.79K |
Scheduled
|
Aug 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| +6.44% | 8.28K |
$15.76 | $130,485.54 | 136.79K |
Jun 19
| |||
Form 4
| -0.62% | -802.00 |
$27.62 | -$22,149.51 | 128.51K |
Scheduled
|
May 20 - May 21
| ||
Form 4
| +8.13% | 9.67K |
$0.01 | $96.67 | 128.51K |
Feb 7
| |||
Form 4
| -0.40% | -480.00 |
$25.62 | -$12,297.80 | 118.84K |
Scheduled
|
Dec 11
| ||
Form 4
| -0.00% | -1.00 |
$25.82 | -$25.82 | 119.32K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$23.21 | -$724,398.72 | 119.32K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
| -0.66% | -794.00 |
$31.95 | -$25,368.30 | 119.32K |
Scheduled
|
May 17
| ||
Form 4
| -11.91% | -16.14K |
$21.41 | -$794,191.20 | 119.32K |
Scheduled
|
May 7
| ||
Form 4
|
—
|
0
|
$25.40 | -$30,185.00 | 135.46K |
Scheduled
|
Jan 31
| ||
Form 4
| +31.04% | 32.08K |
$18.45 | -$30,974.16 | 135.46K |
Scheduled
|
Jan 24
| ||
Form 4
|
—
|
0
|
$26.82 | -$34,430.00 | 103.38K |
Scheduled
|
Jan 17
| ||
Form 4
|
—
|
0
|
$25.17 | -$29,495.00 | 103.38K |
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
$26.31 | -$32,920.00 | 103.38K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$26.45 | -$33,335.00 | 103.38K |
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
$26.56 | -$33,665.00 | 103.38K |
Scheduled
|
Dec 20
| ||
Form 4/A
| -0.46% | -480.00 |
$26.98 | -$53,453.00 | 103.38K |
Scheduled
|
Dec 13
| ||
Form 4
| -1.91% | -1.98K |
$38.62 | -$76,458.00 | 101.88K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
$30.02 | -$44,030.00 | 103.86K |
Scheduled
|
Dec 6
| ||
Form 4
|
—
|
0
|
$29.78 | -$43,310.00 | 103.86K |
Scheduled
|
Nov 29
| ||
Form 4
|
—
|
0
|
$31.42 | -$38,835.00 | 104.56K |
Scheduled
|
Nov 22
| ||
Form 4
| -0.68% | -707.00 |
$31.09 | -$68,735.07 | 103.86K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$29.98 | -$34,530.00 | 103.86K |
Scheduled
|
Nov 8
| ||
Form 4
|
—
|
0
|
$29.40 | -$65,580.00 | 103.86K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$27.37 | -$26,685.00 | 103.86K |
Scheduled
|
Oct 18
| ||
Form 4
|
—
|
0
|
$26.91 | -$126,600.00 | 103.86K |
Scheduled
|
Oct 11
| ||
Form 4
|
—
|
0
|
$27.03 | -$25,680.00 | 299.21K |
Scheduled
|
Sep 6
| ||
Form 4
|
—
|
0
|
$26.74 | -$123,975.00 | 103.86K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +13.31% | 12.2K |
$0.01 | $122.00 | 103.86K |
Feb 2
| |||
Form 4
| -5.56% | -5.22K |
$27.47 | -$143,405.50 | 88.71K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +6.46% | 5.7K |
$0.01 | $57.00 | 93.93K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 4
| +279.76% | 65K |
$0.01 | $650.00 | 88.23K |
May 6
| |||
Form 4
| +19.43% | 3.78K |
$0.01 | $37.80 | 23.23K |
Mar 17
| |||
Form 4
| +10.95% | 1.92K |
—
|
—
| 19.45K |
Dec 11
| |||
| No matching records found | |||||||||
Pathfinder Cell Therapy, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||